MedTrace Logo

Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms

NCT04368156 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2022-01-31

No results posted yet for this study

Summary

The purpose of this study is to asses the efficacy of the Gammacore device reducing the need for mechanical ventilation in patients diagnosed of Covid-19

Conditions

Interventions

DEVICE

gammaCore® (Vagus nerve stimulation)

Vagus nerve stimulation using the gammacore neurostimulation device

Sponsors & Collaborators

  • Carlos Tornero

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2021-02-17
Completion
2021-02-17
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04368156 on ClinicalTrials.gov